Sandbox lung cancer differential: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
* Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.  
* Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.  
* '''<u>The following table summarizes the differentiation of various lung tumors based on histological and topographical features:</u>'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>  
* '''<u>The following table summarizes the differentiation of various lung tumors based on histological and topographical features:</u>'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>  
{| class="wikitable"
{| class="wikitable"
! colspan="11" |Benign Lung Tumors<ref name="pmid23077446">{{cite journal |vauthors=Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK |title=Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging |journal=Radiol Oncol |volume=46 |issue=2 |pages=106–13 |date=June 2012 |pmid=23077446 |pmc=3472932 |doi=10.2478/v10019-012-0021-3 |url=}}</ref>
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign Lung Tumors<ref name="pmid23077446">{{cite journal |vauthors=Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK |title=Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging |journal=Radiol Oncol |volume=46 |issue=2 |pages=106–13 |date=June 2012 |pmid=23077446 |pmc=3472932 |doi=10.2478/v10019-012-0021-3 |url=}}</ref>
|-
|-
! colspan="3" |Benign lung tumor
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign lung tumor
!Risk/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk/Epidemiology
!Pleuripotent cells
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cells
!Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
!Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
!Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
!Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
!Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
!Metastasis
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
|-
| rowspan="2" |'''[[Papilloma]]'''<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| rowspan="2" style="background:#DCDCDC;" align="center" + |'''[[Papilloma]]'''<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| colspan="2" |'''[[Squamous cell papilloma]]'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]'''
|
|
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
Line 45: Line 46:
* N/A
* N/A
|-
|-
| colspan="2" |'''Glandular papilloma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Glandular papilloma'''
|
|
* Rare
* Rare
Line 69: Line 70:
* N/A
* N/A
|-
|-
| rowspan="3" |'''Adenom'''a<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Adenom'''a<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| colspan="2" |'''Alveolar adenoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Alveolar adenoma'''
|
|
* Mean age of diagnosis is 53 years
* Mean age of diagnosis is 53 years
Line 107: Line 108:
* N/A
* N/A
|-
|-
| colspan="2" |'''Papillary adenoma'''<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenoma'''<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
|
|
* Mean age of diagnosis is 32 years
* Mean age of diagnosis is 32 years
Line 140: Line 141:
* N/A
* N/A
|-
|-
| colspan="2" |'''Mucinous cystadenoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma'''
|
|
* No sex predilection  
* No sex predilection  
Line 166: Line 167:
* N/A
* N/A
|-
|-
! colspan="11" |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
|-
|-
! colspan="3" |Variants of lung carcinoma
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
!Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
!Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
!Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
!Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
!Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
!Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
!Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
!Metastasis
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
|-
| rowspan="4" |'''[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]] (SCC)'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| rowspan="4" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]] (SCC)'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| colspan="2" |'''Papillary'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary'''
| rowspan="4" |
| rowspan="4" |
* Cigarette smokers  
* Cigarette smokers  
Line 207: Line 208:
| rowspan="4" |
| rowspan="4" |
|-
|-
| colspan="2" |'''Clear cell'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell'''
|
|
* Cells with clear [[cytoplasm]]
* Cells with clear [[cytoplasm]]
|-
|-
| colspan="2" |'''Small cell'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Small cell'''
|
|
* Poorly differentiated cells
* Poorly differentiated cells
Line 218: Line 219:
* Intercellular bridges or [[keratinization]]
* Intercellular bridges or [[keratinization]]
|-
|-
| colspan="2" |'''Basaloid'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid'''
|
|
* Peripheral palisading of nuclei.
* Peripheral palisading of nuclei.
* Poor differentiation
* Poor differentiation
|-
|-
| colspan="3" |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
|
|
* [[Smoking]]
* [[Smoking]]
Line 254: Line 255:
* Liver
* Liver
|-
|-
| rowspan="10" |'''[[Adenocarcinoma]]'''<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>
| rowspan="10" style="background:#DCDCDC;" align="center" + |'''[[Adenocarcinoma]]'''<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>
| colspan="2" |'''Acinar adenocarcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma'''
| rowspan="10" |
| rowspan="10" |
* [[Smoking]]
* [[Smoking]]
Line 294: Line 295:
* Liver
* Liver
|-
|-
| colspan="2" |'''Papillary adenocarcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma'''
|
|
* [[Papillae]]  
* [[Papillae]]  
Line 302: Line 303:
* [[Mucinous]] or non-mucinous
* [[Mucinous]] or non-mucinous
|-
|-
| rowspan="3" |'''Bronchio-alveolar carcinoma'''
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma'''
|'''Non-mucinous'''
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous'''
|
|
* [[Clara cell|Clara cells]]
* [[Clara cell|Clara cells]]
* [[Pneumocytes|Type II cells]]
* [[Pneumocytes|Type II cells]]
|-
|-
|'''Mucinous'''
| style="background:#DCDCDC;" align="center" + |'''Mucinous'''
|
|
* Low grade differentiation
* Low grade differentiation
Line 318: Line 319:
* Cytologic atypia  
* Cytologic atypia  
|-
|-
|'''Mixed non-mucinous and mucinous or indeterminate'''
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate'''
|
|
|-
|-
| rowspan="5" |'''Solid adenocarcinoma with mucin production'''
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Solid adenocarcinoma with mucin production'''
|'''Fetal adenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Fetal adenocarcinoma'''
|
|
* Consists glandular elements:
* Consists glandular elements:
Line 330: Line 331:
** Rounded morules of polygonal cells with abundant [[eosinophilic]] and finely granular [[cytoplasm]]
** Rounded morules of polygonal cells with abundant [[eosinophilic]] and finely granular [[cytoplasm]]
|-
|-
|'''Mucinous (“colloid”) carcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Mucinous (“colloid”) carcinoma'''
|
|
* Dissecting pools of [[mucin]] containing [[neoplastic]] cells
* Dissecting pools of [[mucin]] containing [[neoplastic]] cells
|-
|-
|'''Mucinous cystadenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma'''
|
|
* Partial [[fibrous tissue]] capsule  
* Partial [[fibrous tissue]] capsule  
Line 340: Line 341:
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
|-
|-
|'''Signet ring adenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma'''
|
|
|-
|-
|'''Clear cell adenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Clear cell adenocarcinoma'''
|
|
|-
|-
| rowspan="5" |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| colspan="2" |'''Basaloid large cell carcinoma of the lung'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid large cell carcinoma of the lung'''
| rowspan="5" |
| rowspan="5" |
* Approximately 10% of lung cancers
* Approximately 10% of lung cancers
Line 383: Line 384:
* [[Pericardium]]
* [[Pericardium]]
|-
|-
| colspan="2" |'''Clear cell carcinoma of the lung'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung'''
|
|
* [[Clear cell|Clear cells]]
* [[Clear cell|Clear cells]]
|-
|-
| colspan="2" |'''Lymphoepithelioma-like carcinoma of the lung'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung'''
|
|
* Syncytial growth pattern
* Syncytial growth pattern
Line 395: Line 396:
* [[Amyloid]] deposition
* [[Amyloid]] deposition
|-
|-
| colspan="2" |'''Large-cell lung carcinoma with rhabdoid phenotype'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype'''
|
|
* [[Eosinophilic]] [[cytoplasmic]] globules
* [[Eosinophilic]] [[cytoplasmic]] globules
Line 401: Line 402:
* [[Eosinophilic]] inclusions
* [[Eosinophilic]] inclusions
|-
|-
| colspan="2" |'''Mixed type'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type'''
|
|
* Mixture of:  
* Mixture of:  
Line 409: Line 410:
** Spindle cell carcinoma
** Spindle cell carcinoma
|-
|-
| rowspan="5" |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| colspan="2" |'''Carcinosarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Carcinosarcoma'''
| rowspan="5" |
| rowspan="5" |
* Accounts for only 0.3-1.3% of all lung malignancies
* Accounts for only 0.3-1.3% of all lung malignancies
Line 441: Line 442:
* [[Kidney]]
* [[Kidney]]
|-
|-
| colspan="2" |'''Spindle cell carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma'''
|
|
* Only spindle shaped tumor cells
* Only spindle shaped tumor cells
Line 453: Line 454:
* [[TTF-1]]  
* [[TTF-1]]  
|-
|-
| colspan="2" |'''Giant cell carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma'''
|
|
* Multi- and/or mononucleated tumor [[giant cells]]
* Multi- and/or mononucleated tumor [[giant cells]]
|-
|-
| colspan="2" |'''Pleomorphic carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleomorphic carcinoma'''
|
|
* Poorly differentiated
* Poorly differentiated
Line 463: Line 464:
* Fibrous or myxoid [[stroma]]
* Fibrous or myxoid [[stroma]]
|-
|-
| colspan="2" |'''Pulmonary blastoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma'''
|
|
* Biphasic  
* Biphasic  
Line 473: Line 474:
* [[Chromogranin A]]  
* [[Chromogranin A]]  
|-
|-
|'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| colspan="2" |'''Typical carcinoid'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid'''
'''Atypical carcinoid'''  
'''Atypical carcinoid'''  
|
|
Line 507: Line 508:
* [[Bone]]
* [[Bone]]
|-
|-
| rowspan="3" |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>  
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>  
| colspan="2" |'''[[Mucoepidermoid carcinoma]]'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]'''
|
|
* Most patients presents in the third and fourth decade
* Most patients presents in the third and fourth decade
Line 539: Line 540:
* [[Brain]]
* [[Brain]]
|-
|-
| colspan="2" |'''Adenoid cystic carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma'''
|
|
* Constitutes less than 1% of all lung tumors
* Constitutes less than 1% of all lung tumors
Line 576: Line 577:
* [[Adrenal glands]]
* [[Adrenal glands]]
|-
|-
| colspan="2" |'''Epithelial-myoepithelial carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma'''
|
|
* Age ranges from 33 to 71 years  
* Age ranges from 33 to 71 years  
Line 600: Line 601:
* [[Breast]]
* [[Breast]]
|-
|-
| rowspan="3" |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>  
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>  
| colspan="2" |'''Squamous carcinoma in situ'''  
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ'''  
| rowspan="3" |
| rowspan="3" |
* Most commonly seen in fifth or sixth decades
* Most commonly seen in fifth or sixth decades
Line 641: Line 642:
* [[Spleen]]
* [[Spleen]]
|-
|-
| colspan="2" |'''Atypical adenomatous hyperplasia'''  
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia'''  
|
|
* Surfactant apoprotein  
* Surfactant apoprotein  
Line 672: Line 673:
* Ground-glass opacity  
* Ground-glass opacity  
|-
|-
| colspan="2" |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
|
|
* [[Pulmonary]] [[neuroendocrine cells]]
* [[Pulmonary]] [[neuroendocrine cells]]
Line 698: Line 699:
* Thickened [[bronchial]] and bronchiolar walls
* Thickened [[bronchial]] and bronchiolar walls
|-
|-
| rowspan="8" |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>  
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>  
| colspan="2" |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
|
|
* Caucasian
* Caucasian
Line 739: Line 740:
* [[Soft tissue]]
* [[Soft tissue]]
|-
|-
| colspan="2" |'''Pleuropulmonary blastoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma'''
|
|
* Most common in children
* Most common in children
Line 777: Line 778:
* [[Pancreas]]
* [[Pancreas]]
|-
|-
| colspan="2" |'''Chondroma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma'''
|
|
* Young women
* Young women
Line 806: Line 807:
* [[Benign tumor]]
* [[Benign tumor]]
|-
|-
| colspan="2" |'''Congenital peribronchial myofibroblastic tumor'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor'''
|
|
* Rare
* Rare
Line 837: Line 838:
|
|
|-
|-
| colspan="2" |'''Diffuse pulmonary lymphangiomatosis'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse pulmonary lymphangiomatosis'''
|
|
* Children
* Children
Line 869: Line 870:
|
|
|-
|-
| colspan="2" |'''Inflammatory myofibroblastic tumor'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Inflammatory myofibroblastic tumor'''
|
|
* Previous [[viral infections]]
* Previous [[viral infections]]
Line 912: Line 913:
* Rare
* Rare
|-
|-
| colspan="2" |'''Pulmonary artery sarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary artery sarcoma'''
|
|
* Mean age of diagnosis is 49.3 years
* Mean age of diagnosis is 49.3 years
Line 951: Line 952:
* [[Mediastinum]]
* [[Mediastinum]]
|-
|-
| colspan="2" |'''Pulmonary vein sarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma'''
|
|
* Most common in women
* Most common in women

Revision as of 18:14, 21 March 2018

  • Differentiation of primary and secondary lung tumors is difficult due to overlapping histologic features.
  • Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.
  • The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]
Benign Lung Tumors[2]
Benign lung tumor Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[3] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[4] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[5]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[6]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma (SCC)[7] Papillary
  • Central
  • Exophytic
  • Intra-epithelial
  • Without invasion
Clear cell
Small cell
  • Poorly differentiated cells
  • Focal squamous
  • No characteristic nuclear features of SCC
  • Intercellular bridges or keratinization
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[8]
  • Bronchial precursor cell
  • White-tan, soft, friable perihilar masses
  • Extensive necrosis
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • Bone marrow
  • Liver
Adenocarcinoma[9][10][11] Acinar adenocarcinoma
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation
  • Lobulated or ill defined edges
  • Irregular-shaped glands
  • Malignant cells:
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Epithelial markers (AE1/AE3, CAM 5.2)
  • Carcinoembryonic antigen
  • CK7
  • TTF-1
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
Papillary adenocarcinoma
Bronchio-alveolar carcinoma Non-mucinous
Mucinous
  • Low grade differentiation
  • Composed of:
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
Mucinous (“colloid”) carcinoma
Mucinous cystadenocarcinoma
Signet ring adenocarcinoma
Clear cell adenocarcinoma
Large cell carcinoma[12] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers
  • Smoking
  • Soft, pink-tan tumor
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
Clear cell carcinoma of the lung
Lymphoepithelioma-like carcinoma of the lung
Large-cell lung carcinoma with rhabdoid phenotype
Mixed type
Sarcomatoid carcinoma[13] Carcinosarcoma
  • Central or peripheral
  • Upper lobes
  • No specific imaging features 
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
Giant cell carcinoma
Pleomorphic carcinoma
Pulmonary blastoma
Carcinoid tumor[14] Typical carcinoid

Atypical carcinoid

  • Atypical carcinoid is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
Salivary gland tumors[15] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Gray-white or tan polypoid lesions
  • Size ranges from 1–4 cm
  • Infiltrative margins
  • Invades other cell layers
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association with smoking
  • Endobronchial
  • Solid to gelatinous in texture
  • White to gray in colour
Preinvasive lesions[16] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Micropapillomatosis
Atypical adenomatous hyperplasia
  • Multiple grey to yellow foci
  • 1mm to 10mm in size
  • Typically not visualized on radiographs
  • Small non-solid nodules
  • Ground-glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Endobronchial
  • Early lesions are:
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are:
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Mesenchymal tumors[17] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women
  • Endothelial cells
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
Chondroma
  • Young women
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
Congenital peribronchial myofibroblastic tumor
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance
  • Hemorrhage
  • Necrosis
  • Well circumscribed
  • Opaque hemithorax
  • Heterogeneous mass
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Prominence of the bronchovascular bundles along
  • Anastomosing endothelial-lined cells along lymphatic routes
  • Increased interstitial markings
Inflammatory myofibroblastic tumor
  • Localized to bronchi
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non-encapculated
  • Calcifications
  • No local invasion
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
  • Rare
Pulmonary artery sarcoma
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Hemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
Pulmonary vein sarcoma
  • Most common in women
  • Mean age of diagnosis is 49
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel
  • 3.0- 20.0 cm
  • Invasion of wall of the vein
  • N/A

Differentiation of lung cancer from other diseases with similar presentation

The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[18][19][20][21][22]

Disease Clinical features

Signs & symptoms

Radiological Findings Characterstic feature
Fever Cough Hemoptysis Dyspnea Chest pain Weight loss Night sweats
High-grade Low grade Productive Dry
Acute Lung abscess + - + - - - + - -
  • Air fluid level
Malignancy

(primary lung cancer)

- + - + + - - + +
  • Coin-shaped lesion
  • Thick wall(>15mm)
  • Ground glass opacities 
Pulmonary Tuberculosis + - + - + - - - +
Necrotizing Pneumonia + - + + - + - -
  • Multiple cavitary lesions
Empyema + - + - + + + - -
Bronchiectasis - - + - + - - - -
  • Linear lucencies
  • Tram tracking appearance
  • Clustered cysts
  • CT confirms the diagnosis
Wegners granulomatosis - - + + + - - -
  • Seen mostly in female age group of 40-55 years
  • Traid of Upper , lower respiratory tract and kidney disease
  • Biopsy of involved organ confirms granulomas
Sarcoidosis + - + - + - - + +
Rheumatoid nodule - - - - - + - + -
Langerhans cell Histiocytosis - - - - - + + + -
  • Thin-walled cystic cavities
Bronchiolitis obliterans - - + - + + + - -
  • Ground-glass opacities
  • Biopsy

References

  1. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  2. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  3. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  4. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  5. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  6. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  7. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  8. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  9. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  11. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  12. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  13. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  14. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  15. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  16. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  17. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  18. Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  19. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  20. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  21. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  22. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.